Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.
Dealbreaker on MSN
Eli Lilly expands its in vivo ambitions, acquiring cell therapy startup Orna for up to $2.4B
Lilly is the latest pharma company to use M&A to enter this growing field, following deals made in the past year by ...
PETRONAS has launched the Malaysia Bid Round 2026 (MBR 2026), offering nine exploration blocks and six discovered resource ...
This raise will set the company up for years. The post Massive capital raise to progress drug trials announced appeared first ...
The business, which employed 80 people in 2022, has appointed administrators in a bid to save the firm.
Carlsberg AS (CABGY) reports robust financial performance with significant revenue and profit increases, while exploring strategic opportunities in India and integrating Britvic.
At the McCourt School of Public Policy, 95% of graduates secured policy roles within six months of graduation — backed by ...
Send a note to Brooke Enloe, Taylor Medine and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...
The capital gains tax is levied on any profit made from the sale of an asset in a given year, whether it's a home, a car, stocks and bonds or cryptocurrency. Not everyone pays capital gains tax, ...
Activist investor Ancora to oppose Netflix-Warner Bros deal, backs Paramount bid Activist investor Ancora Holdings has built a stake in Warner Bros Discovery and plans to oppose the media company's ...
The crop protection chemical maker FMC has retained financial and legal advisers to conduct a strategic review that may lead ...
The winter months and chocolate seem to go hand-in-hand. Why is that? It could be because, naturally, when you think of getting warmed up, you think of hot chocolate. And that could be why Troy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results